Institutional Sign In

Go

Zur Rose

Zur Rose's employees rose 8.72% yoy to 2,131 in 2021

By Helgi Analytics - May 7, 2022

Zur Rose employed 2,131 employees in 2021, up 8.72% compared to the previous year. Historically, between 2009 and 2021,...

How Much Does Zur Rose Invests?

By Helgi Analytics - May 20, 2022

Zur Rose invested a total of CHF 63.5 mil in 2021, up 6.1% compared to the previous year. Historically, between 2009 - 2...

Zur Rose - What Do Customers Bring?

By Helgi Analytics - May 20, 2022

Zur Rose made a net profit of with revenues of in 2021, up by 0% and up by 0%, respectively, compared to the previous year....

Profit Statement 2019 2020 2021
Sales #NAME? ... ... ...
Gross Profit CHF mil 209 251 263
EBITDA #NAME? ... ... ...
EBIT #NAME? ... ... ...
Financing Cost #NAME? ... ... ...
Pre-Tax Profit #NAME? ... ... ...
Net Profit #NAME? ... ... ...
Dividends CHF mil 0 0 0
Balance Sheet 2019 2020 2021
Total Assets #NAME? ... ... ...
Non-Current Assets CHF mil 564 739 732
Current Assets #NAME? ... ... ...
Working Capital #NAME? ... ... ...
Shareholders' Equity #NAME? ... ... ...
Liabilities CHF mil 586 747 784
Total Debt CHF mil 438 571 569
Net Debt #NAME? ... ... ...
Ratios 2019 2020 2021
ROE % ... ... ...
ROCE % ... ... ...
EBITDA Margin % ... ... ...
EBIT Margin % ... ... ...
Net Margin % ... ... ...
Net Debt/EBITDA ... ... ...
Net Debt/Equity % ... ... ...
Cost of Financing % ... ... ...
Valuation 2019 2020 2021
Market Capitalisation USD mil ... ... ...
Enterprise Value (EV) USD mil ... ... ...
Number Of Shares mil 8.66 10.5 11.5
Share Price #NAME? ... ... ...
EV/EBITDA ... ... ...
EV/Sales ... ... ...
Price/Earnings (P/E) ... ... ...
Price/Book Value (P/BV) ... ... ...
Dividend Yield % ... ... ...

Get all company financials in excel:

Download Sample   $19.99

overview Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
income statement                                      
Sales #NAME?             834 880 ... ... ... ... ... ... ... ... ... ... ...
Gross Profit CHF mil ... ... ... ... ... ... ... ... ... ... 209                
EBIT #NAME?             8.44 -7.09 ... ... ... ... ... ... ... ... ... ... ...
Net Profit #NAME?             3.45 -12.8 ... ... ... ... ... ... ... ... ... ... ...
                                         
ROE % ...           4.59 -14.5 ... ... ... ... ... ... ... ... ... ... ...
EBIT Margin %             1.01 -0.806 ... ... ... ... ... ... ... ... ... ... ...
Net Margin %             0.413 -1.45 ... ... ... ... ... ... ... ... ... ... ...
Employees             716 752 1,106 1,314 1,710     ... ... ... ... ... ...
balance sheet                                      
Total Assets #NAME?             233 262 ... ... ... ... ... ... ... ... ... ... ...
Non-Current Assets CHF mil             91.1 102 188 310 564                
Current Assets #NAME?             142 160 ... ... ... ... ... ... ... ... ... ... ...
                                         
Shareholders' Equity #NAME?             72.8 104 ... ... ... ... ... ... ... ... ... ... ...
Liabilities CHF mil             161 158 168 283 586                
Non-Current Liabilities CHF mil             72.0 19.5 48.5 164 374                
Current Liabilities CHF mil             88.7 138 119 119 213                
                                         
Net Debt/EBITDA             2.05 13.9 ... ... ... ... ... ... ... ... ... ... ...
Net Debt/Equity %             44.5 28.5 ... ... ... ... ... ... ... ... ... ... ...
Cost of Financing % ...           4.25 4.40 ... ... ... ... ... ... ... ... ... ... ...
cash flow                                      
Total Cash From Operations CHF mil             18.9 -13.8 -22.2 -33.2 -82.6                
Total Cash From Investing CHF mil             -16.4 -23.1 -62.2 -140 -143                
Total Cash From Financing CHF mil             2.50 37.0 166 297 200                
Net Change In Cash CHF mil             3.97 0.136 82.5 123 -26.0                
valuation                                      
Market Capitalisation USD mil             72.3 320 ... ... ... ... ... ... ... ... ...    
Enterprise Value (EV) USD mil             104 349 ... ... ... ... ... ... ... ... ... ... ...
Number Of Shares mil             3.21 3.55 5.22 6.35 8.66                
Share Price #NAME?             22.5 75.7 ... ... ... ... ...            
Price/Earnings (P/E)             21.0 -21.0 ... ... ... ... ... ... ... ... ... ... ...
Price/Cash Earnings (P/CE)             6.68 -75.5 ... ... ... ... ... ... ... ... ... ... ...
EV/EBITDA             6.54 165 ... ... ... ... ... ... ... ... ... ... ...
Price/Book Value (P/BV)             0.992 2.59 ... ... ... ... ... ... ... ... ... ... ...
Dividend Yield %             0 0 ... ... ... ... ... ... ... ... ...    
income statement Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
income statement                                      
Sales #NAME?             834 880 ... ... ... ... ... ... ... ... ... ... ...
Cost of Goods & Services CHF mil ... ... ... ... ... ... ... ... ... ... 1,147                
Gross Profit CHF mil ... ... ... ... ... ... ... ... ... ... 209                
Selling, General & Admin CHF mil             34.1 43.7 61.1 66.2 88.1     ... ... ... ... ... ...
Research & Development CHF mil             0 0 0 0 0     ... ... ... ... ... ...
Other Operating Expense CHF mil             791 839 958 1,158 1,329     ... ... ... ... ... ...
Staff Cost CHF mil             53.7 60.2 78.3 93.7 117     ... ... ... ... ... ...
Other Operating Cost (Income) CHF mil             6.33 5.40 9.74 3.07 42.0     ... ... ... ... ... ...
EBITDA #NAME?             15.8 2.12 ... ... ... ... ... ... ... ... ... ... ...
Depreciation CHF mil             7.36 9.21 17.1 18.9 31.9                
EBIT #NAME?             8.44 -7.09 ... ... ... ... ... ... ... ... ... ... ...
Net Financing Cost CHF mil             2.30 2.47 2.30 1.46 4.35                
Financing Cost #NAME?             2.47 2.48 ... ... ... ... ... ... ... ...      
Financing Income CHF mil             0.165 0.013 0 0.237 0.051     ... ... ... ... ... ...
FX (Gain) Loss CHF mil             1.47 0.404 -4.28 3.89 -1.34     ... ... ... ... ... ...
(Income) / Loss from Affiliates CHF mil             0.716 0.630 -0.134 -0.173 -0.031     ... ... ... ... ... ...
Extraordinary Cost CHF mil             0 0 0 0 0     ... ... ... ... ... ...
Pre-Tax Profit #NAME?             4.04 -12.7 ... ... ... ... ... ... ... ... ... ... ...
Tax CHF mil             0.598 0.053 -0.241 0.553 2.27                
Minorities CHF mil             0 0 -0.027 -0.129 -0.018     ... ... ... ... ... ...
Net Profit #NAME?             3.45 -12.8 ... ... ... ... ... ... ... ... ... ... ...
Net Profit Avail. to Common CHF mil             3.45 -12.8 -36.2 -39.0 -52.4                
Dividends CHF mil             0 0 0 0 0                
growth rates                                      
Total Revenue Growth % ...           -8.86 5.41 ... ... ... ... ... ... ... ... ... ... ...
Operating Cost Growth % ...           -8.80 7.17 15.6 20.6 16.1     ... ... ... ... ... ...
Staff Cost Growth % ...           -7.08 12.0 30.2 19.6 25.4     ... ... ... ... ... ...
EBITDA Growth % ...           -8.88 -86.6 ... ... ... ... ... ... ... ... ... ... ...
EBIT Growth % ...           2.81 -184 ... ... ... ... ... ... ... ... ... ... ...
Pre-Tax Profit Growth % ...           -10.5 -415 ... ... ... ... ... ... ... ... ... ... ...
Net Profit Growth % ...           -51.8 -471 184 7.54 34.4                
ratios                                      
ROE % ...           4.59 -14.5 ... ... ... ... ... ... ... ... ... ... ...
ROA % ...           1.49 -5.16 ... ... ... ... ... ... ... ... ... ... ...
ROCE % ...           2.63 -9.22 ... ... ... ... ... ... ... ... ... ... ...
EBITDA Margin %             1.89 0.241 ... ... ... ... ... ... ... ... ... ... ...
EBIT Margin %             1.01 -0.806 ... ... ... ... ... ... ... ... ... ... ...
Net Margin %             0.413 -1.45 ... ... ... ... ... ... ... ... ... ... ...
Payout Ratio %             0 0 ... ... ... ... ... ... ... ... ... ... ...
Cost of Financing % ...           4.25 4.40 ... ... ... ... ... ... ... ... ... ... ...
Net Debt/EBITDA             2.05 13.9 ... ... ... ... ... ... ... ... ... ... ...
balance sheet Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
balance sheet                                      
Cash & Cash Equivalents CHF mil             25.5 25.4 108 231 205                
Receivables CHF mil             72.5 71.4 84.0 92.3 127                
Unbilled Revenues CHF mil ... ... ... ... ... ... ... ... 4.72 3.93 0.415                
Inventories CHF mil             34.8 48.3 59.3 69.4 70.6                
Other ST Assets CHF mil             9.49 14.6 17.5 20.3 25.4                
Current Assets #NAME?             142 160 ... ... ... ... ... ... ... ... ... ... ...
Property, Plant & Equipment #NAME?             26.2 26.2 ... ... ... ... ... ... ... ... ... ... ...
LT Investments & Receivables CHF mil             0.697 1.83 0.981 1.08 6.16                
Intangible Assets CHF mil             53.7 63.1 148 265 465                
Goodwill CHF mil             10.5 10.4 83.1 172 335                
Non-Current Assets CHF mil             91.1 102 188 310 564                
Total Assets #NAME?             233 262 ... ... ... ... ... ... ... ... ... ... ...
                                         
Trade Payables CHF mil             72.2 70.7 75.3 83.1 92.1                
Short-Term Debt CHF mil             0.500 50.0 10.4 3.52 87.4                
Other ST Liabilities CHF mil             3.06 3.75 13.0 9.53 6.92                
Current Liabilities CHF mil             88.7 138 119 119 213                
Long-Term Debt CHF mil             57.4 5.00 2.85 145 350                
Other LT Liabilities CHF mil             14.6 14.5 45.6 19.2 23.4                
Non-Current Liabilities CHF mil             72.0 19.5 48.5 164 374                
Liabilities CHF mil             161 158 168 283 586                
Preferred Equity and Hybrid Capital CHF mil             0 0 0 0 0                
Share Capital CHF mil             18.7 24.9 35.8 48.1 262                
Treasury Stock CHF mil             1.03 0.903 1.22 5.45 5.22                
Equity Before Minority Interest CHF mil             72.8 104 294 444 406                
Minority Interest CHF mil             0 0 0.219 0.030 -0.110                
Equity #NAME?             72.8 104 ... ... ... ... ... ... ... ... ... ... ...
growth rates                                      
Total Asset Growth % ...           2.33 12.0 76.6 57.3 36.5                
Shareholders' Equity Growth % ...           -5.91 42.6 183 50.8 -8.58                
Net Debt Growth % ...           -11.9 -8.72 -420 -12.8 -382                
Total Debt Growth % ...           -0.601 -5.09 -75.9 1,019 195                
ratios                                      
Total Debt CHF mil             57.9 55.0 13.2 148 438                
Net Debt #NAME?             32.4 29.6 ... ... ... ... ... ... ... ... ... ... ...
Working Capital #NAME?             35.1 48.9 ... ... ... ... ... ... ... ... ... ... ...
Capital Employed CHF mil             126 151 ... ... ... ... ... ... ... ... ... ... ...
Net Debt/Equity %             44.5 28.5 ... ... ... ... ... ... ... ... ... ... ...
Current Ratio             1.60 1.16 ... ... ... ... ... ... ... ... ... ... ...
Quick Ratio             1.11 0.700 1.61 2.72 1.56                
cash flow Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
cash flow                                      
Net Profit #NAME?             3.45 -12.8 ... ... ... ... ... ... ... ... ... ... ...
Depreciation CHF mil             7.36 9.21 17.1 18.9 31.9                
Non-Cash Items CHF mil             0.631 4.67 2.62 5.26 -34.9     ... ... ... ... ... ...
Change in Working Capital CHF mil             7.43 -14.9 -5.73 -18.4 -27.2                
Total Cash From Operations CHF mil             18.9 -13.8 -22.2 -33.2 -82.6                
                                         
Capital Expenditures CHF mil             -15.2 -19.9 -21.6 -31.5 -41.5                
Net Change in LT Investment CHF mil             -0.272 -1.28 -0.121 -0.450 -3.21     ... ... ... ... ... ...
Net Cash From Acquisitions CHF mil             -0.904 -2.15 -40.9 -109 -103     ... ... ... ... ... ...
Other Investing Activities CHF mil             0 0.261 0.432 0.244 4.62                
Total Cash From Investing CHF mil             -16.4 -23.1 -62.2 -140 -143                
                                         
Dividends Paid CHF mil             0 0 0 0 0                
Issuance Of Shares CHF mil             0.034 42.5 222 185 0.495                
Issuance Of Debt CHF mil             4.39 -3.87 -56.1 112 200                
Other Financing Activities CHF mil             -1.92 -1.64 0 0 -0.314     ... ... ... ... ... ...
Total Cash From Financing CHF mil             2.50 37.0 166 297 200                
                                         
Effect of FX Rates CHF mil             -0.999 0.037 1.07 -0.624 -0.450     ... ... ... ... ... ...
Net Change In Cash CHF mil             3.97 0.136 82.5 123 -26.0                
ratios                                      
Days Sales Outstanding days             31.7 29.6 ... ... ... ... ... ... ... ... ... ... ...
Days Sales Of Inventory days ... ... ... ... ... ... ... ... ... ... 22.5                
Days Payable Outstanding days ... ... ... ... ... ... ... ... ... ... 29.3                
Cash Earnings CHF mil             10.8 -3.56 ... ... ... ... ... ... ... ... ... ... ...
Free Cash Flow CHF mil             2.47 -36.9 -84.4 -174 -226                
Capital Expenditures (As % of Sales) %             1.82 2.27 ... ... ... ... ... ... ... ... ... ... ...
other ratios Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
                                       
Employees             716 752 1,106 1,314 1,710     ... ... ... ... ... ...
Cost Per Employee USD per month             6,299 6,634 5,923 6,063 5,864     ... ... ... ... ... ...
Cost Per Employee (Local Currency) CHF per month             6,255 6,667 5,903 5,942 5,726     ... ... ... ... ... ...
Operating Cost (As % of Sales) %             99.7 101 ... ... ... ... ... ... ... ... ... ... ...
Research & Development (As % of Sales) %             0 0 ... ... ... ... ... ... ... ... ... ... ...
Staff Cost (As % of Sales) %             6.44 6.84 ... ... ... ... ... ... ... ... ... ... ...
Effective Tax Rate %             14.8 -0.417 ... ... ... ... ... ... ... ... ... ... ...
Total Revenue Growth (5-year average) % ... ... ... ... ...   11.3 12.5 ... ... ... ... ... ... ... ... ... ... ...
Customers mil ... ... ... ... ... ... ... ... ... 6.00 7.08                
valuation Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
                                       
Market Capitalisation USD mil             72.3 320 ... ... ... ... ... ... ... ... ...    
Enterprise Value (EV) USD mil             104 349 ... ... ... ... ... ... ... ... ... ... ...
Number Of Shares mil             3.21 3.55 5.22 6.35 8.66                
Share Price #NAME?             22.5 75.7 ... ... ... ... ...            
EV/EBITDA             6.54 165 ... ... ... ... ... ... ... ... ... ... ...
Price/Earnings (P/E)             21.0 -21.0 ... ... ... ... ... ... ... ... ... ... ...
Price/Cash Earnings (P/CE)             6.68 -75.5 ... ... ... ... ... ... ... ... ... ... ...
P/FCF             29.2 -7.27 ... ... ... ... ... ... ... ... ... ... ...
Price/Book Value (P/BV)             0.992 2.59 ... ... ... ... ... ... ... ... ... ... ...
Dividend Yield %             0 0 ... ... ... ... ... ... ... ... ...    
Free Cash Flow Yield %             3.44 -11.5 ... ... ... ... ... ... ... ... ... ... ...
Earnings Per Share (EPS) CHF             1.07 -3.60 -6.94 -6.14 -6.04                
Cash Earnings Per Share CHF             3.37 -1.00 ... ... ... ... ... ... ... ... ... ... ...
Free Cash Flow Per Share CHF             0.770 -10.4 -16.2 -27.3 -26.1                
Book Value Per Share CHF             22.7 29.3 ... ... ... ... ... ... ... ... ... ... ...
Dividend Per Share CHF             0 0 ... ... ... ... ... ... ... ...      
EV/Sales             0.124 0.398 ... ... ... ... ... ... ... ... ... ... ...
EV/EBIT             12.2 -49.4 ... ... ... ... ... ... ... ... ... ... ...
EV/Free Cash Flow             41.8 -9.49 ... ... ... ... ... ... ... ... ... ... ...
EV/Capital Employed             0.843 2.36 ... ... ... ... ... ... ... ... ... ... ...
Earnings Per Share Growth % ...           -52.0 -436 92.8 -11.5 -1.63                
Cash Earnings Per Share Growth % ...           -33.5 -130 ... ... ... ... ... ... ... ... ... ... ...
Book Value Per Share Growth % ...           -5.77 29.0 ... ... ... ... ... ... ... ... ... ... ...
Market Value per Customer USD ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...    
clients & arpu Unit 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027
                                       
Customers mil ... ... ... ... ... ... ... ... ... 6.00 7.08                
Basket Size (USD) USD ... ... ... ... ... ... ... ... ... 71.5 64.6     ... ... ... ... ... ...
Order Frequency ... ... ... ... ... ... ... ... ... 2.60 2.40     ... ... ... ... ... ...
Repeat Order Rate % ... ... ... ... ... ... ... 84.0 87.0 81.0 79.0     ... ... ... ... ... ...
Site Visits mil ... ... ... ... ... ... ... ... ... 146 216     ... ... ... ... ... ...
Marketing Expenses CHF mil ... ... ... ... ... ... ... 22.2 33.7 41.3 53.2     ... ... ... ... ... ...
Marketing Expenses (As % of Sales) % ... ... ... ... ... ... ... 2.53 ... ... ... ... ... ... ... ... ... ... ...

Get all company financials in excel:

Download Sample   $19.99

Zur Rose's net profit fell 64.3% yoy to CHF -17.6 mil in 4Q2019

By Helgi Analytics - August 3, 2020

Zur Rose made a net profit of CHF -17.6 mil with revenues of CHF 344 mil in 4Q2019, down by 64.3% and up by 13.7%, respectively, compared to the previous year. This translates into a net margin of -5.13%. On the operating level, EBITDA reached CHF -5.69 m...

Zur Rose's Total Cash From Operations fell 239% yoy to CHF -33.6 mil in 4Q2019

By Helgi Analytics - August 3, 2020

Zur Rose's operating cash flow stood at CHF -33.6 mil in 4Q2019, down 239% when compared to the previous year. Historically, between 1Q2009 - 4Q2019, the firm’s operating cash flow reached a high of CHF 5.23 mil in 3Q2012 and a low of CHF -33.6 mil ...

Zur Rose's Cash & Cash Equivalents remain unchanged yoy at CHF mil in 4Q2019

By Helgi Analytics - October 12, 2020

Zur Rose's total assets reached CHF 992 mil at the end of 4Q2019, up 36.5% compared to the previous year. Current assets amounted to CHF 428 mil, or 43.2% of total assets while cash stood at CHF 205 mil at the end of 4Q2019. ...

Zur Rose's price/earnings (P/E) fell 200% yoy to -21.0 in 2016

By Helgi Analytics - May 20, 2022

Zur Rose stock traded at 75.7 #NAME? per share at the end 2016 translating into a market capitalization of USD 320 mil. Since the end of 2011, stock has appreciated by 331% representing an annual average growth of 34.0%. In absolute terms, the value of t...

Zur Rose's net profit fell 471% yoy to -12.8 #NAME? in 2016

By Helgi Analytics - May 20, 2022

Zur Rose made a net profit of -12.8 #NAME? with revenues of 880 #NAME? in 2016, down by 471% and up by 5.41%, respectively, compared to the previous year. This translates into a net margin of -1.45%. Historically, between 2009 - 2016, the firm’...

Zur Rose's Net Debt/EBITDA rose 579% yoy to 13.9 in 2016

By Helgi Analytics - May 20, 2022

Zur Rose's net debt stood at 29.6 #NAME? and accounted for 28.5% of equity at the end of 2016. The ratio is down 16.0 pp compared to the previous year. Historically, the firm’s net debt to equity reached a high of 47.5% in 2014 and a low of 8...

Zur Rose's Share Price rose 236% yoy to 75.7 #NAME? in 2016

By Helgi Analytics - May 20, 2022

Zur Rose stock traded at 75.7 #NAME? per share at the end 2016 implying a market capitalization of USD 320 mil. Since the end of 2011, stock has appreciated by 331% implying an annual average growth of 34.0% In absolute terms, the value of the company ros...

Zur Rose's Net Margin fell 452% yoy to -1.45% in 2016

By Helgi Analytics - May 20, 2022

Zur Rose made a net profit of -12.8 #NAME? with revenues of 880 #NAME? in 2016, down by 471% and up by 5.41%, respectively, compared to the previous year. This translates into a net margin of -1.45%. Historically, between 2009 and 2016, the firm’s...

Zur Rose's ROCE fell 451% yoy to -9.22% in 2016

By Helgi Analytics - May 20, 2022

Zur Rose made a net profit of -12.8 #NAME? in 2016, down 471% compared to the previous year. Historically, between 2009 and 2016, the company's net profit reached a high of 40.6 #NAME? in 2009 and a low of -15.5 #NAME? in 2013. The result implies a return...

Zur Rose's P/FCF fell 125% yoy to -7.27 in 2016

By Helgi Analytics - May 20, 2022

Zur Rose stock traded at 75.7 #NAME? per share at the end 2016 translating into a market capitalization of USD 320 mil. Since the end of 2011, the stock has appreciated by 331% representing an annual average growth of 34.0%. At the end of 2016, the firm t...

More News

The Swiss Zur Rose Group is Europe’s largest e-commerce pharmacy and one of the leading medical wholesalers in Switzerland. The Company also operates the leading marketplace in southern Europe for consumer health, beauty and personal care products commonly sold in pharmacies. The company is internationally present with strong brands, including Germany’s best-known pharmacy brand DocMorris. Zur Rose employs more than 1,800 people at sites in Switzerland, Germany, the Netherlands, Spain and France. The Company's activities are divided into two business segments: Zur Rose and DocMorris. The Zur Rose division includes wholesale business and provides drugs to medical doctors, health insurance companies, hospitals and healthcare companies, among others. The DocMorris division manages the mail-order business for drug retail. The Company operates in Switzerland, Germany and the Netherlands through a number of subsidiaries, such as Zur Rose Suisse AG, Zur Rose Pharma GmbH, BlueCare AG, DocMorris NV, Eurapon Pharmahandel GmbH and Vitalsana BV.

Zur Rose Logo

Finance

Zur Rose has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of in 2027, or of sales. That’s compared to % average margin seen in last five years.

The company netted in 2027 implying ROE of and ROCE of . Again, the average figures were % and %, respectively when looking at the previous 5 years.

Zur Rose’s net debt amounted to at the end of 2027, or of equity. When compared to EBITDA, net debt was x, up when compared to average of x seen in the last 5 years.

Valuation

Zur Rose stock traded at 120 #NAME? per share at the end of 2027 resulting in a market capitalization of USD 1,511 mil. Over the previous five years, stock price grew by 0% or 0% a year on average. The closing price put stock at a 12-month trailing EV/EBITDA of x and price to earnings (PE) of x as of 2027.